PHILIPS NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.74 EUR | +2.49% |
|
+4.75% | -6.36% |
| 26/04 | ResMed tops quarterly profit estimates on strong demand for sleep apnea devices | RE |
| 23/04 | PHILIPS NV : Jefferies reiterates its Sell rating | ZD |
Chart calendar Philips NV
142abc2da08186995e84ced0d3af5bb7.X11C8dz12lGvkR8bcn72asGxscuRwNmfNViXjSjbTfI.PRkbwJGYtWXH43haOA6UXezfyPPlob_6eQnB5h-4F5EZbCm9pYaOZvn_Kw~ad29f10c5a9b6f01b387bbba268a88ad
Upcoming events on Philips NV
Past events on Philips NV
| 18/03/2024 | DeGroof Petercam Benelux Conference |
| 13/03/2024 | HIMSS Conference |
| 12/03/2024 | Barclays Global Healthcare Conference |
| 11/03/2024 | Roadshow - Jefferies |
| 01/03/2024 | Roadshow - HSBC - Day 3 |
| 29/02/2024 06:30 pm | European Radiology Congress |
| 29/02/2024 03:00 pm | European Radiology Congress |
| 29/02/2024 | Roadshow - HSBC - Day 2 |
| 28/02/2024 | Roadshow - HSBC - Day 1 |
| 27/02/2024 | Morgan Stanley European MedTech and Life Sciences Conference |
| 26/02/2024 | Roadshow - HSBC |
| 08/02/2024 | Roadshow - ODDO |
| 07/02/2024 | Roadshow - ODDO |
| 07/02/2024 | Roadshow - Day 2 |
| 06/02/2024 | Roadshow - Day 1 |
| 01/02/2024 | Roadshow - Oddo |
| 01/02/2024 | Roadshow - Goldman Sachs |
| 31/01/2024 | Roadshow - Day 2 |
| 30/01/2024 | Roadshow - Day 1 |
| 29/01/2024 02:30 pm | Q4 2023 Earnings Call |
Past dividends on Philips NV
| 12/05/2022 | Annual 0.85 EUR |
| 10/05/2021 | Annual 0.85 EUR |
| 13/05/2019 | Annual 0.85 EUR |
| 07/05/2018 | Annual 0.8 EUR |
| 15/05/2017 | 0.8 EUR |
| 18/05/2016 | 0.8 EUR |
| 13/05/2015 | 0.8 EUR |
| 08/05/2014 | 0.8 EUR |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 19 482 19 561 -0.4% | 19 535 19 583 -0.25% | 17 156 17 287 -0.76% | 17 827 17 434 2.25% | 18 169 18 482 -1.69% | 18 801 |
|
EBITDA Million EUR | Released Forecast Spread | 3 615 3 365 7.44% | 3 709 3 496 6.08% | 2 985 3 092 -3.47% | 2 305 2 072 11.23% | 2 845 2 872 -0.95% | 3 089 |
|
EBIT Million EUR | Released Forecast Spread | 2 563 2 409 6.41% | 2 570 2 361 8.85% | 2 054 2 067 -0.64% | 1 318 1 133 16.37% | 1 921 1 938 -0.85% | 2 073 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 529 1 706 -10.38% | 1 490 1 690 -11.83% | 509 704 -27.72% | -1 731 -1 425 -21.51% | -526 -112 -371.62% | 870 |
|
Net income Million EUR | Released Forecast Spread | 1 167 1 298 -10.09% | 1 187 1 250 -5.01% | 3 319 3 406 -2.54% | -1 608 -1 496 -7.46% | -466 -238 -95.45% | 702 |
|
EPS EUR | Released Forecast Spread | 1,22 1,25 -2.6% | 1,23 1,32 -6.27% | 3,49 3,75 -6.86% | -1,74 -1,43 -21.51% | -0,51 -0,19 -168.05% | 0,71 |
| Announcement Date | 28/01/20 | 25/01/21 | 24/01/22 | 30/01/23 | 29/01/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 8 554 8 439 1.36% | 8 057 7 937 1.51% | 4 944 4 926 0.36% | 3 918 3 803 3.03% | 4 177 4 224 -1.11% | 8 095 8 084 0.14% | 4 310 4 358 -1.1% | 5 422 5 009 8.24% | 4 167 3 990 4.44% | 4 470 4 452 0.41% | 4 471 4 423 1.08% | 5 062 5 381 -5.93% | 4 193 | 4 579 | 4 733 | 5 431 |
|
EBITDA Million EUR | Released Forecast Spread | 896 971 -7.75% | |||||||||||||||
|
EBIT Million EUR | Released Forecast Spread | 662 534 23.97% | 243 232 4.89% | 216 328 -34.15% | 459 571 -19.61% | 209 339 -38.35% | 651 404 61.34% | 359 207 73.15% | 453 400 13.25% | 457 423 8.17% | 653 666 -1.88% | ||||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 7,00 149 -95.3% | 130 77,0 68.83% | ||||||||||||||
|
Net income Million EUR | Released Forecast Spread | 246 93,0 164.52% | 157 216 -27.19% | -151 291 -151.85% | -22,0 76,6 -128.73% | -173 -79,0 -118.99% | -1 330 -1 169 -13.76% | -106 -133 20.13% | 72,0 59,3 21.41% | 88,0 105 -16.34% | 39,0 389 -89.98% | -16,5 | 64,1 | 161 | 294 | ||
|
EPS EUR | Released Forecast Spread | 0,17 0,63 -72.82% | -0,16 0,31 -152.16% | -0,02 0,09 -122.16% | -1,44 -1,27 -13.44% | -0,11 0,11 -209.35% | 0,08 0,07 13.25% | 0,09 0,06 42.81% | 0,04 0,42 -90.39% | -0,02 | 0,07 | 0,18 | 0,32 | ||||
| Announcement Date | 20/07/20 | 26/07/21 | 24/01/22 | 25/04/22 | 25/07/22 | 25/07/22 | 24/10/22 | 30/01/23 | 24/04/23 | 24/07/23 | 23/10/23 | 29/01/24 | - | - | - | - |
| 29/04/2024 10:30 am | PHILIPS NV: Q1 2024 Earnings Release |
| 29/04/2024 03:30 pm | REVVITY, INC.: Q1 2024 Earnings Release |
| 30/04/2024 03:50 pm | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
| 01/05/2024 01:35 am | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | INMODE LTD.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BRUKER CORPORATION: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | HOLOGIC, INC.: Q2 2024 Earnings Release |
| 03/05/2024 01:35 am | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ILLUMINA, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | QUANTERIX CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for Philips NV
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHIA Stock
- Calendar Philips NV
